Enbrel is an important medication used to treat a variety of autoimmune diseases, including rheumatoid arthritis, ankylosing spondylitis, psoriasis, and more. As a result, it’s important to know who makes this vital drug. In this article, we’ll explore the history of Enbrel, who produces it, and the differences between the versions available on the market today. With this information, you can make an informed decision about which version of Enbrel is right for you. So, let’s take a deeper dive into who makes Enbrel and why it’s so important.
Enbrel is a biologic medicine used to treat autoimmune diseases and is manufactured by the pharmaceutical company Amgen. It is a recombinant protein, derived from DNA technology, and is approved by the FDA to treat diseases such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis. Enbrel works by blocking the action of a specific protein, tumor necrosis factor (TNF) alpha, which is a key mediator of inflammation. Enbrel is administered as a subcutaneous injection and is available in prefilled syringes and autoinjectors.
Who Makes Enbrel?
Enbrel is a medication used to treat immune-mediated diseases such as rheumatoid arthritis, psoriatic arthritis, juvenile idiopathic arthritis, and plaque psoriasis. It is a biotechnologically derived medication manufactured by Pfizer.
Pfizer
Pfizer is a research-based, global pharmaceutical company founded in 1849. Headquartered in New York City, the company has operations in 180 countries and employs over 92,500 people globally. Pfizer is the maker of a range of popular products, including Viagra, Lipitor, and Celebrex.
Enbrel Development
Enbrel was initially developed by Immunex Corporation, a biotechnology company based in Seattle, Washington. In December 2002, Immunex was acquired by Amgen, a biotechnology company based in Thousand Oaks, California. Amgen continued to develop and market Enbrel and other Immunex products. In October 2019, Pfizer acquired the rights to Enbrel from Amgen for a total of $13.4 billion.
How is Enbrel Made?
Enbrel is made using recombinant DNA technology, which involves inserting a gene from one organism into another. The gene used in Enbrel’s production is derived from a human tumor necrosis factor (TNF) gene. This gene is inserted into a Chinese hamster ovary (CHO) cell line, which is then used to produce the active ingredient, etanercept. Etanercept is then purified and formulated into Enbrel.
Where is Enbrel Manufactured?
Enbrel is manufactured at Pfizer’s facilities in Kalamazoo, Michigan and in Freiburg, Germany.
Top 6 Frequently Asked Questions
Who Makes Enbrel?
Answer: Enbrel is a biologic medicine manufactured by Pfizer, a leading global biopharmaceutical company. The drug was first approved by the FDA in 1998, and it is currently used to treat a wide variety of conditions, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis. Enbrel works by blocking a protein that is involved in inflammation and by stimulating the production of healthy cells.
What is Enbrel Used For?
Answer: Enbrel is primarily used to treat autoimmune diseases, such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis. It works by blocking a protein that is involved in inflammation and by stimulating the production of healthy cells. Enbrel is a biologic medicine, meaning it is created from living cells, and it is administered by injection.
Who is Enbrel Approved For?
Answer: Enbrel is approved for adults and children four years of age and older with certain autoimmune diseases, such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis. It is not approved for use in pregnant women, and it should not be used in patients with an active infection.
How Is Enbrel Administered?
Answer: Enbrel is administered by injection into the skin. It is available as a single-use prefilled syringe or as a single-dose vial, both of which contain a medicine called etanercept. The medicine is injected into the skin in the upper arm, abdomen, or thigh.
What Are the Possible Side Effects of Enbrel?
Answer: The most common side effects of Enbrel are redness, swelling, and itching at the injection site. Other side effects may include headache, nausea, muscle pain, joint pain, and fatigue. Rare but serious side effects may include blood clots, heart attack, stroke, and a serious allergic reaction.
How Long Does It Take for Enbrel to Work?
Answer: The effects of Enbrel can be seen as early as one to two weeks after the first injection, but it may take up to four to six weeks for the full benefits to be seen. It is important to continue taking Enbrel even if the desired effects are not seen right away.
Enbrel is a revolutionary biologic drug used to treat a variety of autoimmune diseases, including rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Developed by Immunex Corporation, Enbrel is now manufactured and marketed by the multinational biopharmaceutical company Amgen. With its groundbreaking ability to treat a wide range of autoimmune diseases, Enbrel has been a life-changing drug for millions of patients all over the world. Thanks to Amgen’s commitment to innovation, Enbrel continues to provide an effective treatment option for those suffering from autoimmune diseases.